{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,27]],"date-time":"2026-07-27T16:09:44Z","timestamp":1785168584642,"version":"3.55.0"},"reference-count":38,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2009,7,1]],"date-time":"2009-07-01T00:00:00Z","timestamp":1246406400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T00:00:00Z","timestamp":1245974400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2009,7]]},"abstract":"<jats:title>\n                           <jats:bold>Abstract<\/jats:bold>\n                        <\/jats:title>\n          <jats:sec>\n            <jats:title\/>\n            <jats:p>Because of the chronic shortage of liver donors, hepatologists are required to prolong the liver transplant waiting period by preserving the hepatic reserve of scheduled recipients. This study examined the effectiveness of oral branched-chain amino acids (BCAAs), using outcome markers indicating pretransplant hepatic reserve. Fifty-six consecutive eligible patients with Child class A cirrhosis without major complications were randomly assigned to receive oral BCAA granules (12.45 g\/day) for least 1 year or no BCAAs. Differences between groups in the Model for End-Stage Liver Disease (MELD) score, Child-Turcotte-Pugh (CTP) score, asialoscintigraphic clearance index (CI), and complications were examined. Of 50 remaining patients, 27 received BCAAs, and 23 received no BCAAs (mean duration, 3.2 years). The mean annual changes in the MELD score, CTP score, and asialoscintigraphic CI were smaller in the BCAA group than in the control group (\u22120.06 \u00b1 0.23 versus 0.10 \u00b1 0.40, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.024, 0.06 \u00b1 0.30 versus 0.30 \u00b1 0.48, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.037, and 0.00 \u00b1 0.02 versus 0.02 \u00b1 0.04, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.040, respectively). The mean annual changes in the serum total bilirubin and the serum albumin in the BCAA group were better preserved than those in the control group (\u22120.07 \u00b1 0.20 versus 0.12 \u00b1 0.18 mg\/dL, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001, and 0.07 \u00b1 0.13 versus \u22120.02 \u00b1 0.19 g\/dL, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005, respectively); other laboratory variables were not significant. The incidence of overall major cirrhotic complications was lower in the BCAA group than in the control group [14.8% (4 of 27 patients) versus 30.4% (7 of 23 patients) at 3 years, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.043]; only ascites was significant individually. In conclusion, early interventional oral BCAAs might prolong the liver transplant waiting period by preserving hepatic reserve in cirrhosis. Liver Transpl 15:790\u2013797, 2009. \u00a9 2009 AASLD.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1002\/lt.21758","type":"journal-article","created":{"date-parts":[[2009,6,26]],"date-time":"2009-06-26T14:28:15Z","timestamp":1246026495000},"page":"790-797","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":52,"title":["A Randomized Pilot Trial of Oral Branched-Chain Amino Acids in Early Cirrhosis: Validation Using Prognostic Markers for Pre\u2013Liver Transplant Status"],"prefix":"10.1097","volume":"15","author":[{"given":"Etsushi","family":"Kawamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiki","family":"Habu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyasu","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaru","family":"Enomoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joji","family":"Kawabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Tamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeru","family":"Saeki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norifumi","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susumu","family":"Shiomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-16-20250326","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jhep.2004.11.006","article-title":"Liver transplantation in Europe: is there a room for improvement?","volume":"42","author":"Adam","year":"2005","journal-title":"J Hepatol"},{"key":"R2-16-20250326","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/PPO.0b013e31816a5c1f","article-title":"Surgical resection of hepatocellular carcinoma.","volume":"14","author":"Duffy","year":"2008","journal-title":"Cancer J"},{"key":"R3-16-20250326","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis.","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med"},{"key":"R4-16-20250326","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1016\/j.transproceed.2004.12.168","article-title":"Liver transplantation using livers from septuagenarian and octogenarian donors: an underused strategy to reduce mortality on the waiting list.","volume":"37","author":"Pirenne","year":"2005","journal-title":"Transplant Proc"},{"key":"R5-16-20250326","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1053\/jlts.2003.50090","article-title":"MELD score predicts 1year patient survival postorthotopic liver transplantation.","volume":"9","author":"Saab","year":"2003","journal-title":"Liver Transpl"},{"key":"R6-16-20250326","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2169\/internalmedicine.37.429","article-title":"Preferential use of branchedchain amino acids as an energy substrate in patients with liver cirrhosis.","volume":"37","author":"Kato","year":"1998","journal-title":"Intern Med"},{"key":"R7-16-20250326","first-page":"1525","article-title":"Longterm oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial.","volume":"84","year":"1997","journal-title":"Br J Surg"},{"key":"R8-16-20250326","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1016\/S0016-5085(03)00323-8","article-title":"Nutritional supplementation with branchedchain amino acids in advanced cirrhosis: a doubleblind, randomized trial.","volume":"124","author":"Marchesini","year":"2003","journal-title":"Gastroenterology"},{"key":"R9-16-20250326","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S1386-6346(02)00267-X","article-title":"Effect of oral supplementation with branchedchain amino acid granules on serum albumin level in the early stage of cirrhosis: a randomized pilot trial.","volume":"25","author":"Habu","year":"2003","journal-title":"Hepatol Res"},{"key":"R10-16-20250326","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1053\/jhep.2001.22172","article-title":"A model to predict survival in patients with endstage liver disease.","volume":"33","author":"Kamath","year":"2001","journal-title":"Hepatology"},{"key":"R11-16-20250326","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1002\/bjs.1800600817","article-title":"Transection of the oesophagus for bleeding oesophageal varices.","volume":"60","author":"Pugh","year":"1973","journal-title":"Br J Surg"},{"key":"R12-16-20250326","first-page":"1652","article-title":"Clinical usefulness of scintigraphy with 99mTcgalactosylhuman serum albumin for prognosis of cirrhosis of the liver.","volume":"40","author":"Sasaki","year":"1999","journal-title":"J Nucl Med"},{"key":"R13-16-20250326","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S1386-6346(03)00205-5","article-title":"Natural course of changes in hepatic functional reserve in patients with chronic liver diseases evaluated by scintigraphy with GSA.","volume":"27","author":"Kawamura","year":"2003","journal-title":"Hepatol Res"},{"key":"R14-16-20250326","first-page":"79","article-title":"Evaluation of fulminant hepatic failure by scintigraphy with technetium99mGSA.","volume":"38","author":"Shiomi","year":"1997","journal-title":"J Nucl Med"},{"key":"R15-16-20250326","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0261-5614(97)80022-2","article-title":"ESPEN guidelines for nutrition in liver disease and transplantation.","volume":"16","author":"Plauth","year":"1997","journal-title":"Clin Nutr"},{"key":"R16-16-20250326","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S1542-3565(05)00017-0","article-title":"Effects of oral branchedchain amino acid granules on eventfree survival in patients with liver cirrhosis.","volume":"3","author":"Muto","year":"2005","journal-title":"Clin Gastroenterol Hepatol"},{"key":"R17-16-20250326","first-page":"1820","article-title":"Ultrasonographic diagnosis of degree of chronic type C liver disease.","volume":"52","author":"Habu","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"R18-16-20250326","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1034\/j.1399-0012.1999.130111.x","article-title":"Increased early morbidity and mortality with acceptable longterm function in severely obese patients undergoing liver transplantation.","volume":"13","author":"Sawyer","year":"1999","journal-title":"Clin Transplant"},{"key":"R19-16-20250326","doi-asserted-by":"crossref","first-page":"3097","DOI":"10.1016\/j.transproceed.2004.10.047","article-title":"Incidence, predisposing factors, and results of surgical treatment of incisional hernia after orthotopic liver transplantation.","volume":"36","author":"Piazzese","year":"2004","journal-title":"Transplant Proc"},{"key":"R20-16-20250326","doi-asserted-by":"crossref","first-page":"G1292","DOI":"10.1152\/ajpgi.00510.2003","article-title":"Branchedchain amino acids improve glucose metabolism in rats with liver cirrhosis.","volume":"288","author":"Nishitani","year":"2005","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"R21-16-20250326","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1872-034X.2007.00081.x","article-title":"The effect of supplementation with branchedchain amino acids in patients with liver cirrhosis.","volume":"37","author":"Urata","year":"2007","journal-title":"Hepatol Res"},{"key":"R22-16-20250326","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1207\/S15327914nc391_17","article-title":"Effect of the molar ratio of branchedchain to aromatic amino acids on growth and albumin mRNA expression of human liver cancer cell lines in a serumfree medium.","volume":"39","author":"Saito","year":"2001","journal-title":"Nutr Cancer"},{"key":"R23-16-20250326","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-2036.2004.01920.x","article-title":"Longterm oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial.","volume":"19","author":"Poon","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"R24-16-20250326","first-page":"204","article-title":"Overweight and obesity increase the risk for liver cancer in patients with liver cirrhosis and longterm oral supplementation with branchedchain amino acid granules inhibits liver carcinogenesis in heavier patients with liver cirrhosis.","volume":"35","author":"Muto","year":"2006","journal-title":"Hepatol Res"},{"key":"R25-16-20250326","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/j.1872-034X.2008.00319.x","article-title":"Suppressive effect of oral administration of branchedchain amino acid granules on oxidative stress and inflammation in HCVpositive patients with liver cirrhosis.","volume":"38","author":"Ohno","year":"2008","journal-title":"Hepatol Res"},{"key":"R26-16-20250326","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.transproceed.2004.03.095","article-title":"Liver transplant recipients mortality on the waiting list: longterm comparison to ChildPugh classification and MELD.","volume":"36","author":"Boin","year":"2004","journal-title":"Transplant Proc"},{"key":"R27-16-20250326","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1016\/j.transproceed.2007.02.070","article-title":"Impact of pretransplant MELD score on posttransplant outcome in orthotopic liver transplantation for patients with acuteonchronic hepatitis B liver failure.","volume":"39","author":"Wang","year":"2007","journal-title":"Transplant Proc"},{"key":"R28-16-20250326","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1053\/jlts.2003.50027","article-title":"A correlation between the pretransplantation MELD score and mortality in the first two years after liver transplantation.","volume":"9","author":"Onaca","year":"2003","journal-title":"Liver Transpl"},{"key":"R29-16-20250326","doi-asserted-by":"crossref","first-page":"2274","DOI":"10.1016\/j.transproceed.2004.09.004","article-title":"Smallforsize graft in adult livingdonor liver transplantation.","volume":"36","author":"Lee","year":"2004","journal-title":"Transplant Proc"},{"key":"R30-16-20250326","first-page":"426","article-title":"Preoperative determination of the surgical procedure for hepatectomy using technetium99mgalactosyl human serum albumin (99mTcGSA) liver scintigraphy.","volume":"25","author":"Kwon","year":"1997","journal-title":"Hepatology"},{"key":"R31-16-20250326","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1006\/bbrc.1995.2391","article-title":"Changes in the ratio of branchedchain to aromatic amino acids affect the secretion of albumin in cultured rat hepatocytes.","volume":"214","author":"Okuno","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"R32-16-20250326","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0006-291X(03)00295-X","article-title":"Branchedchain amino acids promote albumin synthesis in rat primary hepatocytes through the mTOR signal transduction system.","volume":"303","author":"Ijichi","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"R33-16-20250326","doi-asserted-by":"crossref","first-page":"E503","DOI":"10.1152\/ajpendo.00084.2002","article-title":"Leucine is a directacting nutrient signal that regulates protein synthesis in adipose tissue.","volume":"283","author":"Lynch","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"R34-16-20250326","doi-asserted-by":"crossref","first-page":"8671","DOI":"10.1128\/MCB.21.24.8671-8683.2001","article-title":"Amino acidinduced translation of TOP mRNAs is fully dependent on phosphatidylinositol 3kinasemediated signaling, is partially inhibited by rapamycin, and is independent of S6K1 and rpS6 phosphorylation.","volume":"21","author":"Tang","year":"2001","journal-title":"Mol Cell Biol"},{"key":"R35-16-20250326","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1136\/gut.46.1.114","article-title":"Haemodynamic, renal sodium handling, and neurohormonal effects of acute administration of low dose losartan, an angiotensin II receptor antagonist, in preascitic cirrhosis.","volume":"46","author":"Girgrah","year":"2000","journal-title":"Gut"},{"key":"R36-16-20250326","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/014860718601000117","article-title":"Effects of amino acid infusions on liver regeneration after partial hepatectomy in the rat.","volume":"10","author":"Rigotti","year":"1986","journal-title":"J Parenter Enterol Nutr"},{"key":"R37-16-20250326","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/0168-8278(91)90857-8","article-title":"Effect of glucose and branched chain amino acid (BCAA) infusion on onset of liver regeneration and plasma amino acid pattern in partially hepatectomized rats.","volume":"13","author":"Holecek","year":"1991","journal-title":"J Hepatol"},{"key":"R38-16-20250326","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.bbrc.2007.04.093","article-title":"Leucine stimulates HGF production by hepatic stellate cells through mTOR pathway.","volume":"358","author":"Tomiya","year":"2007","journal-title":"Biochem Biophys Res Commun"}],"container-title":["Liver Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21758","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Flt.21758","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.lww.com\/01445473-200907000-00016","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,29]],"date-time":"2025-03-29T14:47:30Z","timestamp":1743259650000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/01445473-200907000-00016"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7]]},"references-count":38,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2009]]}},"URL":"https:\/\/doi.org\/10.1002\/lt.21758","relation":{},"ISSN":["1527-6465"],"issn-type":[{"value":"1527-6465","type":"print"}],"subject":[],"published":{"date-parts":[[2009,7]]}}}